Sentinel Lymph node biopsy for patients with early stage breast cancer update The ASCO recommendations are similar to those proposed in the ABS Summary Statement: Management of the Malignant Axilla in Early Breast Cancer and are supported by the ABS.
The ASCO recommendations are similar to those proposed in the ABS Summary Statement: Management of the Malignant Axilla in Early Breast Cancer and are supported by the ABS.
American Society for Clinical Oncology (ASCO), USA | USA
01.01.2016
Added: 01.02.2018
Classifications: Breast & Oncoplastic Surgery
Keywords: Axilla Sentinel Lymph Node Biopsy/ SLNB